Article info

PDF
Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment

Authors

  1. Correspondence to Dr Charlotta Hedner, Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden; charlotta.hedner{at}med.lu.se
View Full Text

Citation

Hedner C, Borg D, Nodin B, et al
Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment

Publication history

  • Received 5 September 2017
  • Revised 23 October 2017
  • Accepted 25 October 2017
  • Published in print 13 November 2017.
  • Published online 14 November 2017.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.